A Clinical Trial Assesses the Use of
a Child's Own Cord-Blood Stem Cells to Treat Autism
Fully produced report in:
mp3PRO format
QuickTime
(MPEG-4/AAC) format
Windows Media Audio
9.2 format
(49 seconds)
--
How
Will You Use This Story? --
(OPEN):
CORD BLOOD REGISTRY AND SACRAMENTO'S SUTTER NEUROSCIENCE
INSTITUTE RECENTLY LAUNCHED THE FIRST F-D-A-APPROVED
CLINICAL-TRIAL TO ASSESS THE USE OF A CHILD'S OWN CORD-BLOOD STEM-CELLS
TO TREAT SELECT-PATIENTS WITH AUTISM. DOCTOR MICHAEL CHEZ
[LIKE "PEZ"] IS THE DIRECTOR OF PEDIATRIC NEUROLOGY AT
SUTTER, AND THE STUDY'S PRINCIPAL-INVESTIGATOR...
(CHEZ):
"WHAT I'M
EXCITED ABOUT THIS STUDY IS THAT WE'RE BASICALLY OPENING THE DOOR AND
SAYING, 'ENOUGH THEORY: LET'S GET TO THIS TEST OF THE IDEA THAT
STEM-CELLS CAN HELP REPAIR DISEASES--AND LET'S PUT IT TO THE TEST.'
WE'RE OPENING THE DOOR TO USING STEM-CELLS IN AUTISM AND MANY OTHER
CONDITIONS THAT HAVE ONLY BEEN THEORY, UP UNTIL THIS POINT."
(CLOSE):
THE STUDY WILL INVOLVE 30 CHILDREN, BETWEEN THE AGES OF TWO AND SEVEN.
FOR MORE INFORMATION, VISIT
"CORD-BLOOD"-DOT-COM-SLASH-"AUTISM".
|